| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |